CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novo Nordisk A/S v. Sanofi-Aventis

1:05-cv-00645

Overview

Case Number 1:05-cv-00645
Filing Date 2005-09-02
Status Terminated
Termination Date 2008-09-26
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Aventis Pharma AG NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Aventis Pharma Deutschland Gmbh Operating Company

Represented By

4 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

John G. Day

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Lauren E. Maguire

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Aventis Pharmaceuticals Inc. Operating Company

Represented By

5 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Jeffrey B. Bove

Novak Druce Connolly Bove + Quigg LLP

Tel: +1 (302) 658-9141

The Nemours Building, 1007 North Orange Street

John G. Day

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Lauren E. Maguire

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Sanofi-Aventis Operating Company

Represented By

5 Attorneys Listed

Tiffany Geyer Lydon

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Steven J. Balick

Ashby & Geddes

Tel: +1 (302) 654-1888
Fax: +1 (302) 654-2067

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

John G. Day

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Lauren E. Maguire

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Eric R. Moran

Email: moran@mbhb.com

Plaintiff

Novo Nordisk A/S NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Anne Shea Gaza

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6727

Rodney Square, 1000 North King Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6582408
Medical device
Filed: 1999-07-08
Issued: 2003-06-24
Expired (Term Ended)
Expires: 2019-07-08

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

0

Denied

0

Pending / Review

6

Motions by Category

Procedural / Extension Motion 5 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
NOTICE OF SERVICE of Novo Nordisk's Responses to Aventis's First Set of Requests for the Production of Documents and Things (Nos. 1-267) re 32 STIPULATION TO EX...
Entry #35 • 2006-04-06 Document →
Procedural / Extension Motion Pending / Under Review
NOTICE OF SERVICE of Novo Nordisk A/S' Responses to Aventis's First Set of Interrogatories to Plaintiff Novo Nordisk (Nos. 1-12) re 32 STIPULATION TO EXTEND TIM...
Entry #36 • 2006-04-06 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME Novo Nordisk A/S's time to respond to Aventis's First Set of Requests to the Plaintiff Novo-Nordisk A/S for the Production of Documen...
Entry #32 • 2006-03-21 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME Pre-Discovery Disclosures to January 20, 2006 - filed by Novo Nordisk A/S. (Cottrell, Frederick) (Entered: 01/18/2006)
Entry #23 • 2006-01-18 Document →
Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/1/2006. Amended Pleadings due by 8/1/2006....
Entry #21 • 2006-01-12 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to move, answer or otherwise respond to complaint to October 6, 2005 - filed by Novo Nordisk A/S, Aventis Pharmaceuticals Inc.. (Bove...
Entry #5 • 2005-09-22 Document →

Docket Entries

(46 total)
Pleading / Complaint

COMPLAINT filed against Sanofi-Aventis, Aventis Pharmaceuticals Inc., Aventis Pharma Deutschland Gmbh, Aventis Pharma AG - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 140515.) - filed by Novo Nordisk A/S. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(mwm, ) (Entered: 09/02/2005)

Entry #1 • 2005-09-02
1
Pleading / Complaint

COMPLAINT filed against Sanofi-Aventis, Aventis Pharmaceuticals Inc., Aventis Pharma Deutschland Gmbh, Aventis Pharma AG - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 140515.) - filed by Novo Nordisk A/S. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(mwm, ) (Entered: 09/02/2005)

Entry #1 • 2005-09-02
2
Pleading / Complaint

COMPLAINT filed against Sanofi-Aventis, Aventis Pharmaceuticals Inc., Aventis Pharma Deutschland Gmbh, Aventis Pharma AG - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 140515.) - filed by Novo Nordisk A/S. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(mwm, ) (Entered: 09/02/2005)

Entry #1 • 2005-09-02
2
Pleading / Complaint

COMPLAINT filed against Sanofi-Aventis, Aventis Pharmaceuticals Inc., Aventis Pharma Deutschland Gmbh, Aventis Pharma AG - Magistrate Consent Notice to Pltf. ( Filing fee $ 250, receipt number 140515.) - filed by Novo Nordisk A/S. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(mwm, ) (Entered: 09/02/2005)

Entry #1 • 2005-09-02
2

Disclosure Statement pursuant to Rule 7.1 filed by Novo Nordisk A/S. (mwm, ) (Entered: 09/02/2005)

Entry #2 • 2005-09-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc